Table 3.

Association between platelet distribution width to platelet count ratio, red cell distribution and red cell distribution width to platelet count ratio and clinicopathological characteristics in breast cancer patients.

Variables	PDW/P			RDW
	Average	SD	p-value	Average	SD	p-value
Age (years)
<50	0.49	0.15	0.018	13.51	1.46	0.36
≥50	0.57	0.21		13.32	1.21
TS
<20	0.56	0.20	0.60	13.29	1.22	0.28
≥20	0.57	0.21		13.45	1.29
NG
1	0.57	0.20	0.37	13.34	1.31	0.98
2, 3	0.55	0.26		13.34	1.20
LN
(−)	0.56	0.19	0.70	13.28	1.18	0.09
(+)	0.57	0.26		13.56	1.43
ER
(−)	0.56	0.25	0.99	13.39	1.38	0.70
(+)	0.56	0.19		13.33	1.20
PgR
(−)	0.58	0.24	0.35	13.49	1.44	0.08
(+)	0.55	0.18		13.24	1.08
HER2
(−)	0.58	0.21	0.018	13.40	1.32	0.10
(+)	0.50	0.18		13.08	0.76
Variables	RPR
	Average	SD	p-value
Age (years)
<50	0.54	0.11	0.0026
≥50	0.63	0.17
TS
<20	0.63	0.17	0.44
≥20	0.61	0.17
NG
1	0.63	0.18	0.16
2, 3	0.61	0.16
LN
(−)	0.62	0.17	0.46
(+)	0.61	0.16
ER
(−)	0.60	0.17	0.29
(+)	0.63	0.17
PgR
(−)	0.62	0.18	0.71
(+)	0.62	0.16
HER2
(−)	0.63	0.17	0.019
(+)	0.57	0.15

Abbreviations: TS, tumour size; NG, nuclear grade; LN, lymph node involvement; ER, oestrogen receptor; PgR, progesterone receptor; HER2, human epidermal growth factor receptor 2; SD, standard deviation; p, p-value; PDW/P, platelet distribution width to platelet count ratio; RDW, red cell distribution width; RPR, red cell distribution width to platelet count ratio.